Genetic disease medicine producer BridgeBio Pharma led the carcinoma therapy developer's latest round, having provided an undisclosed amount in December 2016.

AngelMD has put an undisclosed amount into Otomagnetics, a developer of a magnetic injection delivery system based on research at University of Maryland, College Park.

Dermatology product developer and JLabs graduate Sienna Biopharmaceuticals floated at the middle of its range having raised $86m in venture funding.

The Bright Lifecare spinout, which counts Intel Capital as an investor, has now raised $37m in total, after securing $15m in a round led by HBM Healthcare.

The round, which was co-led by Pfizer, will support clinical trials of Complexa's kidney disease and pulmonary arterial hypertension treatments.

London School of Hygiene and Tropical Medicine has signed a deal with LifeArc for the charity to provide a range of technology transfer services to the institution.